Difference between revisions of "Team:NCKU Tainan/Entrepreneurship"

Line 334: Line 334:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-4 col-12">
 
                 <div class="col-md-4 col-12">
                     <a href="#enterprise"><img id="enterpriseImg"" src="https://static.igem.org/mediawiki/2019/f/f8/T--NCKU_Tainan--HP_enterprise.png" height="200" width="200" style="display:block; margin:1rem auto;"></a>
+
                     <a href="#enterprise"><img id="enterpriseImg"" src="https://static.igem.org/mediawiki/2020/e/e4/T--NCKU_Tainan--entre_visualize.png" height="200" width="200" style="display:block; margin:1rem auto;"></a>
 
                     <div style="text-align:center;">
 
                     <div style="text-align:center;">
                         <h3 style="text-align: center;color:#172544">Enterprise Visits</h3>
+
                         <h3 style="text-align: center;color:#172544">Visualize-Design-Test</h3>
                         <p>Winston Medical Supply Co.</p>
+
                         <p>Strengths and Threats.</p>
                         <p>GeneFerm Biotechnology Co., LTD. </p>
+
                          
                        <p>GenMont Biotech Inc.</p>
+
                        <p>NARLabs (National Applied Research Laboratories)</p>
+
                        <p>Synbio Tech Inc.</p>
+
 
                     </div>     
 
                     </div>     
 
                 </div>
 
                 </div>
 
                 <div class="col-md-4 col-12">
 
                 <div class="col-md-4 col-12">
 
                     <a href="#government">
 
                     <a href="#government">
                         <img id="governmentImg" src="https://static.igem.org/mediawiki/2019/a/ab/T--NCKU_Tainan--HP_government.png" height="200" width="200" style="display:block; margin:1rem auto;">
+
                         <img id="governmentImg" src="https://static.igem.org/mediawiki/2020/8/82/T--NCKU_Tainan--entre_business.png" height="200" width="200" style="display:block; margin:1rem auto;">
 
                     </a>
 
                     </a>
 
                     <div style="text-align: center;">
 
                     <div style="text-align: center;">
                         <h3 style="text-align: center;color:#172544">Government Association</h3>
+
                         <h3 style="text-align: center;color:#172544">Business plan</h3>
                         <p>TFDA (Taiwan Food and Drugs Administrations)</p>
+
                         <p>Realizing through a plan.</p>
                        <p>IPO (Intellectual Property Office)</p>
+
                     
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 365: Line 362:
 
                        
 
                        
 
                 <div class="col-md-2 col-12">
 
                 <div class="col-md-2 col-12">
                     <a href="#expert"><img id="expertImg" src="https://static.igem.org/mediawiki/2019/f/f1/T--NCKU_Tainan--HP_expert.png" height="200" width="200" style="display:block; margin:1rem auto;"></a>
+
                     <a href="#expert"><img id="expertImg" src="https://static.igem.org/mediawiki/2020/c/c4/T--NCKU_Tainan--entre_value.png" height="200" width="200" style="display:block; margin:1rem auto;"></a>
 
                     <div style="text-align: center;">
 
                     <div style="text-align: center;">
                         <h3 style="text-align: center;color:#172544">Expert Visits</h3>
+
                         <h3 style="text-align: center;color:#172544">Value</h3>
                         <p>Healthcare Expert Visits</p>
+
                         <p>The value of our product.</p>
                        <p>Dialysis Center Visit</p>
+
                                             
                        <p>Dry Labs Visits</p>
+
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 381: Line 377:
 
                        
 
                        
 
                 <div class="col-md-2 col-12">
 
                 <div class="col-md-2 col-12">
                     <a href="#enterprise"><img id="enterpriseImg"" src="https://static.igem.org/mediawiki/2019/f/f8/T--NCKU_Tainan--HP_enterprise.png" height="200" width="200" style="display:block; margin:1rem auto;"></a>
+
                     <a href="#enterprise"><img id="enterpriseImg"" src="https://static.igem.org/mediawiki/2020/5/5e/T--NCKU_Tainan--entre_future.png" height="200" width="200" style="display:block; margin:1rem auto;"></a>
 
                     <div style="text-align:center;">
 
                     <div style="text-align:center;">
                         <h3 style="text-align: center;color:#172544">Enterprise Visits</h3>
+
                         <h3 style="text-align: center;color:#172544">Future:</h3>
                         <p>Winston Medical Supply Co.</p>
+
                         <p>Future development.</p>
                         <p>GeneFerm Biotechnology Co., LTD. </p>
+
                          
                        <p>GenMont Biotech Inc.</p>
+
                        <p>NARLabs (National Applied Research Laboratories)</p>
+
                        <p>Synbio Tech Inc.</p>
+
 
                     </div>     
 
                     </div>     
 
                 </div>
 
                 </div>

Revision as of 18:30, 27 October 2020


Entrepreneurship

Educate people of different ages about glaucoma

Overview

This year, iGEM NCKU Tainan combined contact lenses and synthetic biology together to create a new treatment for glaucoma. Therefore, we conducted a survey to know more about how our customers think for contact lens and glaucoma. By this survey, we not only collected the data to learn the habit of customers about wearing contact lenses, but also discovered an enormous problem. People aren't familiar with glaucoma. Hence, we did a lot of HP events to raise public awareness of glaucoma and promote. To learn how to mass produce and sell our product we ask Camax Optical Crop. (and TWBIO).

Consideration

Development and implementation.

Visualize-Design-Test

Strengths and Threats.

Business plan

Realizing through a plan.

Value

The value of our product.

Future:

Future development.



Skills

Programming Languages & Tools
Workflow
  • Mobile-First, Responsive Design
  • Cross Browser Testing & Debugging
  • Cross Functional Teams
  • Agile Development & Scrum



Interests

Apart from being a web developer, I enjoy most of my time being outdoors. In the winter, I am an avid skier and novice ice climber. During the warmer months here in Colorado, I enjoy mountain biking, free climbing, and kayaking.

When forced indoors, I follow a number of sci-fi and fantasy genre movies and television shows, I am an aspiring chef, and I spend a large amount of my free time exploring the latest technology advancements in the front-end web development world.



Awards & Certifications

  • Google Analytics Certified Developer
  • Mobile Web Specialist - Google Certification
  • 1 st Place - University of Colorado Boulder - Emerging Tech Competition 2009
  • 1 st Place - University of Colorado Boulder - Adobe Creative Jam 2008 (UI Design Category)
  • 2 nd Place - University of Colorado Boulder - Emerging Tech Competition 2008
  • 1 st Place - James Buchanan High School - Hackathon 2006
  • 3 rd Place - James Buchanan High School - Hackathon 2005